Lord, Abbett & Co
CMD

Lord, Abbett & Co’s Cantel Medical Corporation CMD Stock Holding History

Lord, Abbett & Co’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-143,877
Closed -$11.5M – 950
2017
Q1 		$11.5M Buy
143,877
+5,727
+4% +$455K 0.03% 557
2016
Q4 		$10.9M Sell
138,150
-11,000
-7% -$855K 0.03% 545
2016
Q3 		$11.6M Buy
+149,150
New +$10.8M 0.04% 537

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Lord, Abbett & Co's CMD Position: Q2 2017 in Review

Lord, Abbett & Co sold out of Cantel Medical Corporation (CMD) in Q2 2017, closing a stake of 143,877 shares — an estimated $11.5M sold.

Lord, Abbett & Co first reported a position in CMD in Q3 2016 and held it in 3 quarters. The position peaked at $11.6M in Q3 2016. 214 funds tracked by Wall St. Rank hold CMD as of Q2 2017.

  • Lord, Abbett & Co reported no remaining Cantel Medical Corporation position as of Q2 2017 after selling out during the quarter.
  • Lord, Abbett & Co sold 143,877 Cantel Medical Corporation shares in Q2 2017, an estimated $11.5M.
  • Lord, Abbett & Co first reported a position in Cantel Medical Corporation in Q3 2016 and held it in 3 quarters.
  • Lord, Abbett & Co's Cantel Medical Corporation position peaked at $11.6M in Q3 2016.
  • 214 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2017.

Based on Lord, Abbett & Co's 13F filing for Q2 2017, filed 14 Aug 2017.